Navigation Links
Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
Date:5/11/2009

virus infection, some state and county public health authorities now only require confirmatory testing for specimens from certain high risk patients or under certain circumstances.

With the availability of the Focus Diagnostics Influenza A H1N1 (Swine Flu) RNA Real-Time RT-PCR Test, physicians will be able to submit patient specimens that are found to be positive for Influenza virus type A through testing performed by a Quest Diagnostics' regional laboratory or other private clinical laboratory to Focus Diagnostics' reference laboratory for novel H1N1 laboratory testing. A physician that believes a patient is at high risk of novel H1N1 infection may order the new Focus Diagnostics test to aid the diagnosis of Influenza virus type A infection, including the novel H1N1 virus. Focus Diagnostics would also submit those test specimens found to be positive as well as the test results to the appropriate public health authorities, as required by local public health guidelines.

"The availability of the new Focus Diagnostics laboratory test will enable physicians and hospitals to quickly identify patients infected with S-OIV and differentiate them from patients infected with other Influenza A strains," said Jay M. Lieberman, M.D., medical director, Focus Diagnostics. "We will continue to aid our public health colleagues in responding to the H1N1 outbreak, and encourage clinicians to follow testing guidelines provided by public health authorities."

Focus Diagnostics has collaborated with the U.S. Centers for Disease Control and Prevention, the World Health Organization and other public health agencies to help identify and develop diagnostic tests for emerging infectious diseases. Focus Diagnostics was instrumental in developing the first laboratory developed test for West Nile Virus after it was identified in New York in 1999. Focus Diagnostics also introduced the first laboratory developed test for SARS and the first FDA-cl
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
2. Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State
3. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
4. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
5. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
6. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
7. Previous Claims of siRNA Therapeutic Effects Called into Question by Report in Human Gene Therapy
8. ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
9. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
10. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
11. Colorado Cancer Research Program Will Host Golf Event to Drive the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... TORONTO , May 4, 2015 ... that it intends to dividend to its stockholders a ... a definitive licensing agreement to license its RapidMist™ buccal ... (OTCQB:SMFI). As announced on April 23, 2015, ... respect of the licensing of its RapidMist™ buccal drug ...
(Date:5/4/2015)... May 4, 2015 Rogne Bioscience, a privately-held ... announced that preclinical and mechanism of action data will ... of Investigative Dermatology (SID) Annual Meeting being held May ... Atlanta, Georgia . Logo - http://photos.prnewswire.com/prnh/20150501/213318LOGO ... of RON2315, a novel, low MW (<1700 daltons) peptide ...
(Date:5/4/2015)... May 4, 2015   HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of advanced ... Godshall , is scheduled to present at the Bank of ... Las Vegas on Thursday, May 14, 2015, at ... webcast of the Company,s presentation at the conference will be ...
Breaking Medicine Technology:Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 2Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 3Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 4Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split 5Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2HeartWare Presentation At Bank Of America Merrill Lynch 2015 Health Care Conference To Be Webcast 2
... , REDWOOD CITY, Calif., Dec. 24 Maxygen, ... the development of improved versions of protein drugs, today announced ... which expired at 5:00 p.m., New York City time, on ... count by the depositary for the tender offer, Maxygen expects ...
... , , WINNIPEG, Manitoba, Dec. 23 On Dec. ... wholesale reimportation of cheaper prescriptions drugs from abroad, despite projected ... prescription for Americans. , "Americans are still paying up ... Australia, the UK, New Zealand and India," said Gary Ryan, ...
Cached Medicine Technology:Maxygen, Inc. Announces Preliminary Results of Dutch Auction Tender Offer 2Obama Plan Buckles Under Pharma Lobby; Plan to Import Low-Cost Medicines Derails 2Obama Plan Buckles Under Pharma Lobby; Plan to Import Low-Cost Medicines Derails 3
(Date:5/4/2015)... (PRWEB) May 04, 2015 Takeda Pharmaceuticals ... billion to settle thousands of Actos lawsuits ( http://www.theactoslawsuitcenter.com/ ... increases the risk that a patient will develop bladder ... 28th, if 95% of those eligible for the Actos ... 9,000 bladder cancer cases currently pending in courts around ...
(Date:5/4/2015)... “ LiveSchool ” was featured on NewsWatch ... look at the latest and coolest applications on the ... host of AppWatch and technology expert, conducted the app ... teachers to reward students with good behavior. , Positive ... the classroom. And the good people at LiveSchool ...
(Date:5/4/2015)... 04, 2015 Baptist Medical Center ... Association’s Get With The Guidelines®-Stroke Gold Plus Quality ... Roll. The award recognizes the hospital’s commitment and ... most appropriate treatment according to nationally recognized, research-based ... To receive the Gold Plus Quality Achievement Award, ...
(Date:5/4/2015)... 2015 Ticket Down is a reputable source ... (ICC) . While the World Cup is the most ... four years, the International Champions Cup is one of the ... all-time attendance record for soccer in the United States set ... at the University of Michigan. This year, the defending champion ...
(Date:5/4/2015)... 2015 Ticket Down is a reputable source ... Arena in Columbia, South Carolina. Fans of Paul ... “Out There” tour which originally kicked off in 2013. The ... America and the legendary performer recently announced that he would ... Arena on June 21st, in Charlottesville, VA at John Paul ...
Breaking Medicine News(10 mins):Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 2Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 3Health News:Baptist Medical Center Jacksonville Receives Top Honor for Stroke Care 4Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2
... a number of studies have suggested that regular exercise reduces ... and other diseases, such as diabetes its still not ... a link exists, the nature of the relationship is by ... kinesiology and community health researchers at the University of Illinois ...
... underway today when External Affairs Minister Pranab Mukherjee inaugurated ... ,The project is the direct outcome ... in 2004 during the inaugural session of the Pan-African ... said: "We have a long tradition of co-operation between ...
... healthcare has been rapid. A growing number of patients ... they receive. These 'power patients' possess characteristics that distinguish ... in driving the use of the Internet in healthcare. ... treatments received, access to quality information about their care ...
... giant pharmaceutical firm is close to developing the world's first ... battle outbreaks, a news report said Friday. ,Clinical ... next year in Thailand, said Jean Stephenne, GlaxoSmithKline Biologicals president. ... the US Army for 10 years, more or less," The ...
... India making its presence felt on the world fashion ... only eager to walk the ramp here but also ... the years Indian fashion matured as designers stopped copying ... innovative silhouettes as well as becoming a profitable business ...
... expression with the disease process that lies behind chronic fatigue ... blood may hold key information about what goes on in ... by severe, chronic mental and physical exhaustion, arising in a ... conducted by a team of researchers led by Professor Andrew ...
Cached Medicine News:Health News:Exercise Reduces Inflammation 2Health News:Exercise Reduces Inflammation 3Health News:Exercise Reduces Inflammation 4Health News:Mukherjee Inaugurates Tele-education and Tele-medicine Centres in Addis Ababa 2Health News:Benefits From the Use of the Internet in Healthcare Applications Highlighted 2Health News:Benefits From the Use of the Internet in Healthcare Applications Highlighted 3Health News:Indian Fashion Beckons International Models 2
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: